The association between ketamine and esketamine and suicidality: reports to the Food And Drug Administration Adverse Event Reporting System (FAERS)

Introduction Replicated evidence indicates that ketamine and esketamine reduces measures of suicidality in persons with treatment resistant depression (TRD). It remains uncertain whether susceptible individuals may experience worsening of pre-existing suicidality with either agent.